Molina Healthcare, INC Form 4 insider transactions

NYSE
Molina Healthcare, Inc. Director Richard C. Zoretic was granted 180 shares of common stock valued at $55,000 as part of his compensation for services.
NYSE
Molina Healthcare, Inc. Director Dale B. Wolf was granted 180 shares of common stock valued at $306.29 per share as part of his scheduled compensation for services.
NYSE
Molina Healthcare, Inc. Director Richard M. Schapiro was granted 180 shares of common stock on July 1, 2025, as part of his director compensation under the company's 2025 Equity Incentive Plan.
NYSE
Molina Healthcare, Inc. Director Ronna Romney was granted 180 shares of common stock valued at $306.29 per share as part of her director compensation under the 2025 Equity Incentive Plan.
NYSE
Molina Healthcare, Inc. Director Steven J. Orlando reported the future acquisition of 180 shares of common stock on July 1, 2025, as part of his director compensation plan.
NYSE
Molina Healthcare, Inc. Director Stephen H. Lockhart acquired 180 shares of common stock on July 1, 2025, as part of the company's 2025 Equity Incentive Plan for director services.
NYSE
Molina Healthcare, Inc. Director Leo P. Grohowski acquired 180 shares of common stock on July 1, 2025, as part of his director compensation plan.
NYSE
Molina Healthcare, Inc. Director Barbara L. Brasier acquired 180 shares of common stock on July 1, 2025, as part of her director compensation under the company's 2025 Equity Incentive Plan.
NYSE
Molina Healthcare's EVP of Medicaid, Debra Bacon, reported recent stock acquisitions through an employee plan and dispositions for tax withholding, alongside a detailed future vesting schedule for her equity holdings.
NYSE
Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, acquired 85 shares of common stock at $247.39 per share through the company's Employee Stock Purchase Plan, increasing his total beneficial ownership to 72,902 shares.
NYSE
Director Dale B. Wolf sold 1,500 shares of Molina Healthcare (MOH) common stock held by his revocable trust on May 21, 2025, at prices ranging from $320.51 to $324.42.
NYSE
Steven J. Orlando, a director at Molina Healthcare, filed an amended Form 4 (Form 4/A) to correct an omission of 1,500 shares held in his 401(k) from the original filing on May 5, 2025.
NYSE
Director Steven Orlando sold 1,000 shares of Molina Healthcare (MOH) common stock at an average price of $318.58 on May 5, 2025.
NYSE
Director Leo Grohowski reports acquiring 118 shares of Molina Healthcare common stock under the company's 2025 Incentive Plan.
NYSE
Molina Healthcare's CEO, Joseph M. Zubretsky, executed transactions involving the company's common stock, including sales and a trust transfer, as detailed in a recent SEC filing.
NYSE
Director Richard M. Schapiro sold 669 shares of Molina Healthcare, Inc. at an average price of $320.50 on April 29, 2025.
NYSE
Director Richard C. Zoretic acquired 168 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Dale B. Wolf acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Richard M. Schapiro acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Ronna Romney acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Steven J. Orlando acquired 168 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Stephen H. Lockhart acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Daniel Cooperman acquired 56 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's equity incentive plan.
NYSE
Director Barbara Brasier reports acquisition of 168 shares of Molina Healthcare common stock as part of the company's equity incentive plan.
NYSE
Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
NYSE
EVP Debra Bacon reports acquisition and disposal of Molina Healthcare stock related to performance stock units and restricted stock grants.
NYSE
Maurice Hebert, Chief Accounting Officer of Molina Healthcare, reports acquisition and disposal of common stock related to performance stock units and restricted stock grants.
NYSE
James Woys, Chief Operating Officer of Molina Healthcare, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
NYSE
Molina Healthcare's CEO, Joseph Zubretsky, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
NYSE
Molina Healthcare's CFO, Mark Keim, reports acquisition and disposal of company stock, including shares from performance stock units and restricted stock grants.